Diacylglycerol kinase-dependent formation of phosphatidic acid molecular species during interleukin-2 activation in CTLL-2 T-lymphocytes

FEBS Open Bio

Volumn 2, Issue , 2012, Pages 267-272

  Mizuno, Satoru ^a   Sakai, Hiromichi ^a   Saito, Masafumi ^a   Kado, Sayaka ^a   Sakane, Fumio ^a  

^a CHIBA UNIVERSITY   (Japan)

Author keywords

Diacylglycerol kinase; Interleukin 2; Liquid chromatography electrospray ionization mass spectrometry; Phosphatidic acid

Indexed keywords

3 [2 [4 (4,4' DIFLUOROBENZHYDRYLIDENE)PIPERIDINO]ETHYL] 2,3 DIHYDRO 2 THIOXO 4(1H) QUINAZOLINONE; DIACYLGLYCEROL KINASE; INTERLEUKIN 2; PHOSPHATIDIC ACID;

ARTICLE; HUMAN; HUMAN CELL; INTRACELLULAR SIGNALING; LIQUID CHROMATOGRAPHY; MAMMAL CELL; MASS SPECTROMETRY; MOLECULE; PRIORITY JOURNAL; T LYMPHOCYTE;

MURINAE;

EID: 84866000914     PISSN: 22115463     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.fob.2012.08.006     Document Type: Article

References (26)

1. English D. Phosphatidic acid: a lipid messenger involved in intracellular and extracellular signalling. Cell. Signal. 1996, 8:341-347.
2. Exton J.H. Phosphatidylcholine breakdown and signal transduction. Biochim. Biophys. Acta 1994, 1212:26-42.
3. Hodgkin M.N., Pettitt T.R., Martin A., Michell R.H., Pemberton A.J., Wakelam M.J. Diacylglycerols and phosphatidates: which molecular species are intracellular messengers. Trends Biochem. Sci. 1998, 23:200-204.
4. Jang J.H., Lee C.S., Hwang D., Ryu S.H. Understanding of the roles of phospholipase D and phosphatidic acid through their binding partners. Prog. Lipid Res. 2012, 51:71-81.
5. Sakane F., Imai S., Kai M., Yasuda S., Kanoh H. Diacylglycerol kinases: why so many of them. Biochim. Biophys. Acta 2007, 1771:793-806.
6. Goto K., Hozumi Y., Kondo H. Diacylglycerol, phosphatidic acid, and the converting enzyme, diacylglycerol kinase, in the nucleus. Biochim. Biophys. Acta 2006, 1761:535-541.
7. Merida I., Avila-Flores A., Merino E. Diacylglycerol kinases: at the hub of cell signalling. Biochem. J. 2008, 409:1-18.
8. Shulga Y.V., Topham M.K., Epand R.M. Regulation and functions of diacylglycerol kinases. Chem. Rev. 2011, 111:6186-6208.
9. van Blitterswijk W.J., Houssa B. Properties and functions of diacylglycerol kinases. Cell. Signal. 2000, 12:595-605.
10. Sakane F., Imai S., Kai M., Yasuda S., Kanoh H. Diacylglycerol kinases as emerging potential drug targets for a variety of diseases. Curr. Drug Targets 2008, 9:626-640.
11. Yanagisawa K., et al. Diacylglycerol kinase α suppresses tumor necrosis factor-α-induced apoptosis of human melanoma cells through NF-κB activation. Biochim. Biophys. Acta 2007, 1771:462-474.
12. Takeishi K., et al. Diacylglycerol kinase alpha enhances hepatocellular carcinoma progression by activation of Ras-Raf-MEK-ERK pathway. J. Hepatol. 2012, 57:77-83.
13. Sakane F., Yamada K., Kanoh H., Yokoyama C., Tanabe T. Porcine diacylglycerol kinase sequence has zinc finger and E-F hand motifs. Nature 1990, 344:345-348.
14. Yamada K., Sakane F., Kanoh H. Immunoquantitation of 80 kDa diacylglycerol kinase in pig and human lymphocytes and several other cells. FEBS Lett. 1989, 244:402-406.
15. Flores I., Casaseca T., Martinez-A C., Kanoh H., Merida I. Phosphatidic acid generation through interleukin 2 (IL-2)-induced α-diacylglycerol kinase activation is an essential step in IL-2-mediated lymphocyte proliferation. J. Biol. Chem. 1996, 271:10334-10340.
16. Flores I., Jones D.R., Cipres A., Diaz-Flores E., Sanjuan M.A., Merida I. Diacylglycerol kinase inhibition prevents IL-2-induced G1 to S transition through a phosphatidylinositol-3 kinase-independent mechanism. J. Immunol. 1999, 163:708-714.
17. Jones D.R., Flores I., Diaz E., Martinez-A C., Merida I. Interleukin-2 stimulates a late increase in phosphatidic acid production in the absence of phosphlipase D activation. FEBS Lett. 1998, 433:23-27.
18. Jones D.R., Pettitt T.R., Sanjuan M.A., Merida I., Wakelam M.J. Interleukin-2 causes an increase in saturated/monounsaturated phosphatidic acid derived from 1,2-diacylglycerol and 1-O-alkyl-2-acylglycerol. J. Biol. Chem. 1999, 274:16846-16852.
19. Pulfer M., Murphy R.C. Electrospray mass spectrometry of phospholipids. Mass Spectrom. Rev. 2003, 22:332-364.
20. Houjou T., Yamatani K., Imagawa M., Shimizu T., Taguchi R. A shotgun tandem mass spectrometric analysis of phospholipids with normal-phase and/or reverse-phase liquid chromatography/electrospray ionization mass spectrometry. Rapid Commun. Mass Spectrom. 2005, 19:654-666.
21. Bligh E.G., Dyer W.J. A rapid method of total lipid extraction and purification. Can. J. Biochem. Physiol. 1959, 37:911-917.
22. Rouser G., Siakotos A.N., Fleischer S. Quantitative analysis of phospholipids by thin-layer chromatography and phosphorus analysis of spots. Lipids 1966, 1:85-86.
23. Pettitt T.R., McDermott M., Saqib K.M., Shimwell N., Wakelam M.J. Phospholipase D1b and D2a generate structurally identical phosphatidic acid species in mammalian cells. Biochem. J. 2001, 360:707-715.
24. Shui G., Guan X.L., Gopalakrishnan P., Xue Y., Goh J.S., Yang H., et al. Characterization of substrate preference for Slc1p and Cst26p in Saccharomyces cerevisiae using lipidomic approaches and an LPAAT activity assay. PLoS one 2010, 5:e11956.
25. Jeong R.U., Lim S., Kim M.O., Moon M.H. Effect of D-allose on prostate cancer cell lines: phospholipid profiling by nanoflow liquid chromatography-tandem mass spectrometry. Anal. Bioanal. Chem. 2011, 401:689-698.
26. Jiang Y., Sakane F., Kanoh H., Walsh J.P. Selectivity of the diacylglycerol kinase inhibitor 3-2-(4-[bis-(4-fluorophenyl)methylene]-1-piperidinyl)ethyl-2,3-dihydro-2-thioxo-4(1H)quinazolinone (R59949) among diacylglycerol kinase subtypes. Biochem. Pharmacol. 2000, 59:763-772.